From the European Directorate for the Quality of Medicines & HealthCare (EDQM): The EDQM is conducting a survey on the Monocyte-activation test (MAT), as described in European Pharmacopoeia general chapter 2.6.14 to gather information from all users and to facilitate its routine application as an in vitro replacement for the Test for pyrogens. The deadline for responses is 7 March 2013. Participate in the survey: https://www.surveymonkey.com/s/MAT2013 Kristie Sullivan Secretary, ASCCT www.ascctox.org This email was sent to members of the American Society for Cellular and Computational Toxicology. Learn more at www.ascctox.org. To post, send to ascct@xxxxxxxxxxxxx. To unsubscribe, send an email with the subject line "unsubscribe" to ksullivan@xxxxxxxxxxx. To view an archive of list emails, visit www.freelists.org/archive/ascct.